News
Shionogi and NEC collaborate on hepatitis B vaccine
Shionogi and NEC Corporation have announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Shionogi and NEC Corporation have announced the execution of a strategic research collaboration agreement for the development of a novel hepatitis B therapeutic vaccine.